FGF1 — patent landscape

Top predicted compounds (top 20 by supporting neighbours, then confidence)

Compound	Confidence	Supporting neighbours
SCHEMBL3804442	0.62	11/20
SCHEMBL2058821	0.59	9/20
SCHEMBL2059338	0.54	9/20
Sucrosofate (SCHEMBL3086839)	0.48	9/20
Potassium Ion (SCHEMBL380009)	0.32	9/20
Water (SCHEMBL6357796)	0.32	9/20
SCHEMBL4899810	0.64	8/20
SCHEMBL3700622	0.59	8/20
SCHEMBL4895055	0.59	8/20
SCHEMBL4902478	0.59	8/20
SCHEMBL2507113	0.53	8/20
SCHEMBL1787297	0.50	8/20
SCHEMBL4904646	0.70	7/20
SCHEMBL4906384	0.70	7/20
SCHEMBL4180806	0.69	7/20
SCHEMBL3691749	0.68	7/20
SCHEMBL728827	0.61	7/20
SCHEMBL3391119	0.61	7/20
SCHEMBL2059166	0.57	7/20
SCHEMBL3135361	0.57	7/20

Clinical trials — most relevant to FGF1 by text similarity (a relevance ranking, not an exhaustive list)

Trial	Phase	Status
Effect of Etelcalcetide on Cardiac Hypertrophy in Hemodialysis Patients	PHASE4	COMPLETED
Role of Coenzyme Q10 in Chronic Kidney Disease	PHASE4	RECRUITING
Role of Vitamin K2 in Chronic Kidney Disease	PHASE4	RECRUITING
Nintedanib in Lung Transplant Recipients With Bronchiolitis Obliterans Syndrome Grade 0p-1-2	PHASE3	COMPLETED
Fibroblast Growth Factor-1 (FGF-1) for the Treatment of Coronary Heart Disease	PHASE2	UNKNOWN
FGF-1 for Intramuscular Injection for the Treatment of Peripheral Arterial Disease	PHASE1/PHASE2	UNKNOWN
Dovitinib Lactate in Treating Patients With Pancreatic Neuroendocrine Tumors	PHASE2	WITHDRAWN
The Effectiveness of Allogenic Mesenchymal Stem Cells Therapy on Hair Regrowth in Androgenetic Alopecia.	PHASE1/PHASE2	ENROLLING_BY_INVITATION
Vitamin D Deficiency Treatment Outcomes After Non-ST-Segment Elevation Myocardial Infarction	PHASE2	UNKNOWN
Dovitinib(TKI258) in Patients With Castration-resistant Prostate Cancer	PHASE2	COMPLETED
An Open-label Phase II Study With SUTENT in Patients Suffering From Hormone Refractory Prostate Cancer	PHASE2	COMPLETED
In-office Repair of Chronic Tympanic Membrane Perforations	PHASE1/PHASE2	ACTIVE_NOT_RECRUITING
FGF-1 for Topical Administration for the Treatment of Diabetic or Venous Stasis Ulcers	PHASE1	COMPLETED
Safety Study of Topical Human FGF-1 for Wound Healing	PHASE1	UNKNOWN
Gene Expression and Tolerability Study of NV1FGF in Patients With Peripheral Artery Occlusive Disease Planned to Undergo Major Amputation	PHASE1	COMPLETED
Recombinant Human Fibroblast Growth Factor-2 (rhFGF-2) In Gingival Recession Defects	EARLY_PHASE1	COMPLETED
Role of FGF21 in Breast Cancer	nan	NOT_YET_RECRUITING
Vitamin D Deficiency, Insulin Resistance and FGF-23	nan	COMPLETED
Fibroblast Growth Factor-23 (FGF-23) is Independently Associated With Left Ventricular Mass Index (LVMI) and Myocardial Performance Index (MPI) in Haemodialysis Patients	nan	UNKNOWN
Atrial Fibrillation in Relationship to Plasma Biomarkers	nan	UNKNOWN
Effect of Aloe Vera Gel and Manuka Honey on Radiation Induced Oral Mucositis	nan	UNKNOWN
Effectiveness of a rhGM-CSF-containing Gel on Promoting Recovery After 1927-nm Fractional Thulium Fiber Laser Treatment of Atrophic Acne Scars.	nan	COMPLETED
Evaluate the Effect of Growth Hormone (GH) Treatment on Fibroblast Growth Factor 23, a Known Phosphaturic Agent	nan	COMPLETED
Efficacy of Platelet-Rich Plasma Therapy for Androgenetic Alopecia: A Systematic Review and Meta-analysis	nan	UNKNOWN
Baker Cyst Aspiration Combined With Platelet-rich Plasma Injection in Knee Osteoarthritis	nan	COMPLETED
Investigation of Substrates Associated With the Recurrence of Atrial Fibrillation After PV Cryoablation	nan	COMPLETED
Physiologic Regulation of FGF-23	nan	COMPLETED
Bone Markers and Bone Density Changes in Hyperperparathyroid Dialysis Patients Under Cinacalcet Treatment	nan	COMPLETED
Platelet-Rich Plasma for Partial Rotator Cuff Tears	nan	NOT_YET_RECRUITING
Importance of Neurogenic Inflammation in the Angiogenic Response of the Dental Pulp as a Defensive Response	nan	COMPLETED

Related proteins — ESM-2 sequence neighbours (a FGF1 binder may also engage these)

Protein	Name	Similarity
Q5NVQ3	—	1.000	Q5NVQ3 →
P20002	—	1.000	P20002 →
P34004	—	1.000	P34004 →
P61149	—	1.000	P61149 →
P19596	—	1.000	P19596 →
P03968	—	1.000	P03968 →
P61148	—	1.000	P61148 →
Q7SIF8	—	1.000	Q7SIF8 →
Q7M303	—	1.000	Q7M303 →
Q6PBT8	—	0.999	Q6PBT8 →
Q6I6M7	—	0.999	Q6I6M7 →
Q6GLR6	—	0.997	Q6GLR6 →
P48798	—	0.995	P48798 →
P15655	—	0.993	P15655 →
P12226	—	0.992	P12226 →
P13109	—	0.992	P13109 →
P03969	—	0.992	P03969 →
P20003	—	0.991	P20003 →
O89101	—	0.991	O89101 →
P48808	—	0.991	P48808 →
O88182	—	0.991	O88182 →
P48800	—	0.990	P48800 →
Q5RAY8	—	0.990	Q5RAY8 →
Q9N198	—	0.989	Q9N198 →
Q0VCA0	—	0.989	Q0VCA0 →
P21781	—	0.989	P21781 →
P79150	—	0.989	P79150 →
P48799	—	0.988	P48799 →
Q5D0X0	—	0.988	Q5D0X0 →
P36363	—	0.988	P36363 →